Ibalizumab Completed Phase 3 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03913195Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection